Side-by-side comparison of AI visibility scores, market position, and capabilities
India YC accredited virtual school with project-based curriculum and Parent NPS 85; $2.12M LearnStart/Draper/YC seed transitioning from after-school to full-time school in 2023-2024, winning Times Now Most Innovative School 2024 with 27 employees.
StayQrious is an India-based accredited virtual school — backed with $2.12 million in total funding including a $2 million seed in September 2020 led by LearnStart with Draper Associates, Y Combinator, and Lavni Ventures — providing children (K-12 equivalent) with a project-based, accredited online school experience focused on real-world problem-solving and small-group collaborative learning as an alternative to traditional classroom education. After transitioning from an after-school enrichment model to a full-time accredited online school (the pivot occurring from late 2023 to mid-2024), StayQrious has achieved an exceptional Parent NPS (Net Promoter Score) of 85 and won the Times Now 'Most Innovative School' award in 2024, operating with 27 employees as of July 2025 (+59% year-over-year headcount growth).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.